AUC-26839-81081
3 vaccinations
5 coded responses
18 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 014 / MA
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-11
Dose 1 — Moderna
-
2021-01-12
Registered in v-safe
- 2021-01-12
-
2021-01-13
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Good · Site: PainFree text: Mild occasional “tingling†left side face Best described as when Novocaine wears off after dental procedureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-18
-
2021-01-25
Survey response — day 14, dose 1MedDRA: Injection site rash, Paraesthesia — Feeling: GoodFree text: Rash noted to injection site and surrounding area on day 8 9 10 post injection. Intermittent facial tingling that subsided after day 10 but worst was day 8 with tingling going fro left side of face across jaw lasting one hourMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-01
-
2021-02-08
Dose 2 — Moderna
-
2021-02-15
Survey response — day 7, dose 2MedDRA: Back pain, Body temperature increased, Chills, Myalgia, Nausea, Pain in extremity, Paraesthesia — Feeling: GoodFree text: On 02/08/2021 right facial tingling same side as injection of second shot, lasted about 1hr. On 2/9/21 second day from 2nd vaccine, mild nausea, muscle soreness upper and lower extremities and back, intermittent chills. Early evening 99.0 temp with chills. 02/10/21 no symptoms and no symptoms sinceMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-24
- 2021-03-01
- 2021-03-08
- 2021-03-15
-
2021-03-22
Survey response — day 42, dose 2MedDRA: Paraesthesia — Feeling: GoodFree text: Mild facial tingling that was similar to initial injections - was intermittent and short lastingWas not interfering with ADLsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-14
- 2021-08-15
-
2022-02-09
Dose 3 — Moderna
- 2022-02-09
-
2022-05-18
Survey response — 3 months, dose 3MedDRA: Exfoliative rash, Rash — Feeling: GoodFree text: Psoriasis like rashes on both upper arms (small areas) and psoriasis like rashes bilateral shins greater on right than left.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-11 | Moderna | |
| 2 | 2021-02-08 | Moderna | |
| 3 | 2022-02-09 | Moderna | No |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Mild occasional “tingling†left side face Best described as when Novocaine wears off after dental procedure
Release 2 — day 14, dose 1
Symptoms: Rash noted to injection site and surrounding area on day 8 9 10 post injection. Intermittent facial tingling that subsided after day 10 but worst was day 8 with tingling going fro left side of face across jaw lasting one hour
Release 4 — day 7, dose 2
Systemic reaction (other): On 02/08/2021 right facial tingling same side as injection of second shot, lasted about 1hr. On 2/9/21 second day from 2nd vaccine, mild nausea, muscle soreness upper and lower extremities and back, intermittent chills. Early evening 99.0 temp with chills. 02/10/21 no symptoms and no symptoms since
Release 6 — day 42, dose 2
Symptoms: Mild facial tingling that was similar to initial injections - was intermittent and short lastingWas not interfering with ADLs
Release 11 — 3 months, dose 3
Symptoms: Psoriasis like rashes on both upper arms (small areas) and psoriasis like rashes bilateral shins greater on right than left.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exfoliative rash | · | · | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Rash | · | · | ✓ |
| SRO | Back pain | ✓ | ✓ | ✓ |
| SRO | Body temperature increased | ✓ | ✓ | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release